EFFECTS OF ANTI-COPPER THERAPY ON HEPATOCELLULAR MITOCHONDRIA IN PATIENTS WITH WILSONS DISEASE - ULTRASTRUCTURAL AND STEREOLOGICAL STUDY
- 1 January 1976
- journal article
- research article
- Vol. 71 (3) , 457-461
Abstract
Liver biopsy specimens from 7 patients with Wilson''s disease (hepatolenticular degeneration), obtained before and after 3-5 yr of D-penicillamine therapy, were studied by EM and stereology. The characteristic mitochondrial abnormalities encountered in the hepatocytes of untreated patients were less pronounced or disappeared after treatment in 5 of the 7 patients. Relative mitochondrial volume, surface density of the external mitochondrial membranes, and the number of these profiles/unit area increased, whereas abnormal elevations SGOT [serum glutamic oxalacetic transaminase] and SGPT [serum glutamic-pyruvic transaminase] returned to normal levels.This publication has 3 references indexed in Scilit:
- Prevention of Wilson's Disease in Asymptomatic PatientsNew England Journal of Medicine, 1968
- PRACTICAL STEREOLOGICAL METHODS FOR MORPHOMETRIC CYTOLOGYThe Journal of cell biology, 1966
- Penicillamine Therapy for Hepatolenticular DegenerationJAMA, 1964